ibrutinib,rituximab
abbvie,janssen
[' ibru']
#ash22 update: based on our findings, standard chemotherapy plus ibrutinib (with or without autologous stem cell transplantation) is the new standard of care for first-line mcl patients, said dr. martin dreyling. #medtwitter #medonc 
OBR is an oncology-focused digital media company that provides news and information resources to oncology professionals.